257 related articles for article (PubMed ID: 20003209)
1. Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure.
Galindo CL; Skinner MA; Errami M; Olson LD; Watson DA; Li J; McCormick JF; McIver LJ; Kumar NM; Pham TQ; Garner HR
BMC Physiol; 2009 Dec; 9():23. PubMed ID: 20003209
[TBL] [Abstract][Full Text] [Related]
2. Pathological and physiological hypertrophies are regulated by distinct gene programs.
Beisvag V; Kemi OJ; Arbo I; Loennechen JP; Wisløff U; Langaas M; Sandvik AK; Ellingsen Ø
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):690-7. PubMed ID: 19809332
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure.
Schiekofer S; Shiojima I; Sato K; Galasso G; Oshima Y; Walsh K
Physiol Genomics; 2006 Oct; 27(2):156-70. PubMed ID: 16882883
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
[TBL] [Abstract][Full Text] [Related]
5. Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy.
Molojavyi A; Lindecke A; Raupach A; Moellendorf S; Köhrer K; Gödecke A
Physiol Genomics; 2010 Apr; 41(2):137-45. PubMed ID: 20145201
[TBL] [Abstract][Full Text] [Related]
6. Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice.
Rau CD; Romay MC; Tuteryan M; Wang JJ; Santolini M; Ren S; Karma A; Weiss JN; Wang Y; Lusis AJ
Cell Syst; 2017 Jan; 4(1):121-128.e4. PubMed ID: 27866946
[TBL] [Abstract][Full Text] [Related]
7. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
8. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
[TBL] [Abstract][Full Text] [Related]
9. Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure.
Vescovo G; Jones SM; Harding SE; Poole-Wilson PA
J Mol Cell Cardiol; 1989 Oct; 21(10):1047-61. PubMed ID: 2555526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
12. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
[TBL] [Abstract][Full Text] [Related]
13. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
[TBL] [Abstract][Full Text] [Related]
14. Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy.
An X; Wang J; Li H; Lu Z; Bai Y; Xiao H; Zhang Y; Song Y
PLoS One; 2016; 11(2):e0149155. PubMed ID: 26871457
[TBL] [Abstract][Full Text] [Related]
15. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
Das B; Young D; Vasanji A; Gupta S; Sarkar S; Sen S
Cardiovasc Res; 2010 Aug; 87(3):524-34. PubMed ID: 20202977
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
17. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice.
Ren J; Yang L; Tian W; Zhu M; Liu J; Lu P; Li J; Yang L; Qi Z
Cardiology; 2015; 130(3):175-184. PubMed ID: 25720823
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo.
Duan Q; Ni L; Wang P; Chen C; Yang L; Ma B; Gong W; Cai Z; Zou MH; Wang DW
Aging Cell; 2016 Aug; 15(4):625-33. PubMed ID: 27133203
[TBL] [Abstract][Full Text] [Related]
20. Mixed messages: transcription patterns in failing and recovering human myocardium.
Margulies KB; Matiwala S; Cornejo C; Olsen H; Craven WA; Bednarik D
Circ Res; 2005 Mar; 96(5):592-9. PubMed ID: 15718504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
